Diabetes Care Devices Market Global Briefing 2017
出 版 商:TBRC
出版日期:2017/02/06
頁 數:33頁
文件格式:PDF
價 格:
USD 1,000 (Single-User License)
USD 1,500 (Multi-User License)
USD 2,000 (Global-User License)
USD 1,000 (Hard copy)
USD 1,500 (Multi-User License)
USD 2,000 (Global-User License)
USD 1,000 (Hard copy)
The diabetes care devices industry manufactures blood glucose monitoring devices and insulin delivery devices. Diabetes care devices are designed to diagnose, monitor or manage type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar.
The Americas was the largest geographic market in the diabetes care devices market in 2016, accounting for over 50% of the global market. Europe was the second largest geographic market, accounting for around 23% of the global market. Asia was the third largest geographic market, accounting for over 12% of the global market.
The artificial pancreas is a system that measures blood glucose levels on a minute-to-minute basis using a continuous glucose monitor (CGM), and transmits this information to an insulin pump that calculates and releases the required amount of insulin into the body. It consists of three essential components – a glucose sensor system, a control algorithm, and an insulin infusion device. This system is more effective than conventional insulin delivery devices as it automates insulin dosing based on blood sugar levels. Key companies in this industry are focusing on developing such systems. Medtronic recently gained US FDA approval for its artificial pancreas system, MiniMed 670G.
The Americas was the largest geographic market in the diabetes care devices market in 2016, accounting for over 50% of the global market. Europe was the second largest geographic market, accounting for around 23% of the global market. Asia was the third largest geographic market, accounting for over 12% of the global market.
The artificial pancreas is a system that measures blood glucose levels on a minute-to-minute basis using a continuous glucose monitor (CGM), and transmits this information to an insulin pump that calculates and releases the required amount of insulin into the body. It consists of three essential components – a glucose sensor system, a control algorithm, and an insulin infusion device. This system is more effective than conventional insulin delivery devices as it automates insulin dosing based on blood sugar levels. Key companies in this industry are focusing on developing such systems. Medtronic recently gained US FDA approval for its artificial pancreas system, MiniMed 670G.
Figure 1: Global Diabetes Care Devices Market Historic Market Size, 2012 – 2016, USD ($) Billion 6
Figure 2: Global Diabetes Care Devices Market Forecast Market Size, 2016 – 2020, USD ($) Billion 9
Figure 3: Global Diabetes Care Devices Market, Split By Segments, 2016, $ Billion 12
Figure 4: Global Diabetes Care Devices Market, Split By Region, 2016, USD ($) Billion 14
Figure 5: Global Diabetes Care Devices Market Size, Historic and Forecast Growth, Split By Region, 2012 – 2020, Percentage (%) 16
Figure 6: Global Diabetes Care Devices Market, Split By Country, 2016, $ Billion 17
Figure 7: Global Diabetes Care Devices Market, Historic and Forecast Growth Rate, Split By Country, 2012 – 2020 19
Figure 8: Global Diabetes Care Devices Market, Key Competitor Estimated Shares, 2016, Percentage (%) 20
Figure 2: Global Diabetes Care Devices Market Forecast Market Size, 2016 – 2020, USD ($) Billion 9
Figure 3: Global Diabetes Care Devices Market, Split By Segments, 2016, $ Billion 12
Figure 4: Global Diabetes Care Devices Market, Split By Region, 2016, USD ($) Billion 14
Figure 5: Global Diabetes Care Devices Market Size, Historic and Forecast Growth, Split By Region, 2012 – 2020, Percentage (%) 16
Figure 6: Global Diabetes Care Devices Market, Split By Country, 2016, $ Billion 17
Figure 7: Global Diabetes Care Devices Market, Historic and Forecast Growth Rate, Split By Country, 2012 – 2020 19
Figure 8: Global Diabetes Care Devices Market, Key Competitor Estimated Shares, 2016, Percentage (%) 20